Altus Biologics

Altus is a leading life sciences company, which has developed a unique, powerful and proprietary platform technology, known as Crystalomics™, to enable the rapid commercialization of high-value protein-based products. Our primary focus is on the $300 billion pharmaceutical industry, where the technology is designed to significantly accelerate the development of both large and small molecule pharmaceuticals.

Contact Details: 625 Putnam Ave Cambridge MA 02139 United States of America Tel: 617-577-6121 Fax: 617-577-6502 Email: info@altus.com WWW: www.altus.com/

Loading...

Recent Publications by Altus Biologics:
Injectable controlled release formulations incorporating protein crystals. Development of ready-to-inject in situ formable controlled release gel...	17th November, 2004	Department of Pharmaceutics, Altus Biologics Inc., 625 Putnam Ave.,	J Control Release. 2004 Apr 16;96(1):149-58. DOI Direct Link
Capillary electrophoresis in the analysis and monitoring of biotechnological processes. Capillary electrophoresis (CE) became a versatile technique for analysis...	3rd September, 2004	Altus Biologics Inc., Cambridge, MA., USA.	Methods Mol Biol. 2004;276:77-120. DOI Direct Link
Protein crystals for the delivery of biopharmaceuticals. The year 2002 marked the 20th anniversary of the first successful product...	14th July, 2004	Altus Biologics Inc., 625 Putnam Avenue, Cambridge, MA 02139, USA.	Expert Opin Biol Ther. 2004 Mar;4(3):301-17. DOI Direct Link
Protein crystallization: from HTS to kilogram-scale. The first experiments on protein crystallization started randomly during...	2nd June, 2004	Altus Biologics Inc, Process Development, 625 Putnam Avenue, Cambridge, MA	Curr Opin Drug Discov Devel. 2003 Nov;6(6):848-54.
Crystalline monoclonal antibodies for subcutaneous delivery. Therapeutic applications for mAbs have increased dramatically in recent...	23rd July, 2003	Altus Biologics, Inc., 625 Putnam Avenue, Cambridge, MA 02139, USA.	Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):6934-9. Epub 2003 Jun 2. DOI Direct Link
→View more Altus Biologics research publications.

Altus Biologics Patents:
US Patent No.	Title
6541606	Stabilized protein crystals formulations containing them and methods of making them
6500933	Methods of preparing carbohydrate crosslinked glycoprotein crystals
6140475	Controlled dissolution crosslinked protein crystals
6042824	Methods using cross linked protein crystal formulations as catalysts in organic solvents
5932212	Crosslinked protein crystal formulations and their use as catalysts in organic solvents
→View more Altus Biologics patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 482 times since April 2007, the link to the organisation's website has been followed 110 times

Recent Search Terms used to find this page: Altus Biologics | Altus Biologics | Altus Biologics | Altus Biologics | altus biologics | Altus Biologics Inc | altus biologics | altusbio | altus bi | altus biologics | .

Search for more companies in Cambridge

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Altus Biologics